MiR-93-5P Represses the Gluconeogenesis of Hepatocellular Carcinoma while Boosting Its Glycolysis and Malignant Progression by Suppressing PCK1.

MLA

Zhou, Xianfei, et al. “MiR-93-5P Represses the Gluconeogenesis of Hepatocellular Carcinoma While Boosting Its Glycolysis and Malignant Progression by Suppressing PCK1.” Critical Reviews in Eukaryotic Gene Expression, vol. 32, no. 1, 2022, pp. 35–47. EBSCOhost, https://doi.org/10.1615/CritRevEukaryotGeneExpr.2021038907.

APA

Zhou, X., Huang, L., Xing, R., Yang, F., & Nie, H. (2022). MiR-93-5P Represses the Gluconeogenesis of Hepatocellular Carcinoma while Boosting Its Glycolysis and Malignant Progression by Suppressing PCK1. Critical Reviews in Eukaryotic Gene Expression, 32(1), 35–47. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2021038907

Chicago

Zhou, Xianfei, Luoshun Huang, Renwei Xing, Fan Yang, and Hanqiu Nie. 2022. “MiR-93-5P Represses the Gluconeogenesis of Hepatocellular Carcinoma While Boosting Its Glycolysis and Malignant Progression by Suppressing PCK1.” Critical Reviews in Eukaryotic Gene Expression 32 (1): 35–47. doi:10.1615/CritRevEukaryotGeneExpr.2021038907.